Results 181 to 190 of about 311,527 (352)
Sternocleidomastoid Omohyoid Entrapment of the Internal Jugular Vein Causing Vertigo and Headaches
Clinical Otolaryngology, EarlyView.
Yoon‐Hee Cha +3 more
wiley +1 more source
Internal Medicine Journal, EarlyView.Abstract Hyperhidrosis is an under‐reported and under‐treated condition that causes significant patient morbidity. Secondary causes require consideration, but the vast majority of cases are idiopathic. The condition is encountered by a range of clinicians, including neurologists, dermatologists and endocrinologists, and it pays to be familiar with the ...
Mitchell J. Lycett, Karl Ng
wiley +1 more source
Journal of Oral Rehabilitation, EarlyView.ABSTRACT Background Despite various treatment approaches for bruxism, there is limited evidence comparing exercise therapy and occlusal splints, highlighting the importance of this study. Objectives To compare the effects of a 6‐week jaw exercise (JE) program with combined jaw and posture exercises (JP) on pain and mandibular motion in patients with ...
Gul Oznur Karabicak +5 more
wiley +1 more source
Growth and toxin production by Clostridium botulinum in moldy tomato juice [PDF]
, 1976 C. N. Huhtanen +3 more
openalex +1 more source
Journal of Oral Rehabilitation, EarlyView.ABSTRACT Background Bruxism is a parafunctional activity characterised by teeth grinding or clenching, often associated with stress and neurophysiological factors. Its aetiology is multifactorial, with recent studies emphasising neurotransmitters and hormonal imbalances, particularly melatonin and cortisol. This study assesses masseter muscle thickness
Sema Kaya, Alaettin Koç, Zübeyir Huyut
wiley +1 more source
Clostridium botulinum growth and toxin production in tomato juice containing Aspergillus gracilis [PDF]
, 1979 Theron E. Odlaug, I. J. Pflug
openalex +1 more source
Journal of Oral Pathology &Medicine, EarlyView.ABSTRACT Introduction There has been a significant increase in antipsychotic usage, particularly belonging to second‐generation antipsychotics (SGAs), in the management of severe mental illnesses (SMIs) over the past few decades, but their impact on oral health is unclear.
Dileep Sharma +7 more
wiley +1 more source
New Engineered-Botulinum Toxins Inhibit the Release of Pain-Related Mediators. [PDF]
Int J Mol Sci, 2019 Tang M, Meng J, Wang J.
europepmc +1 more source
Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Hemiparesis in Adults with Lower Limb Spasticity Previously Treated With Other Botulinum Toxins: A Secondary Analysis of a Randomized Controlled Trial. [PDF]
PM R, 2020 Esquenazi A +10 more
europepmc +1 more source
Revealing the Patient Perspective: Evolution of Patient-Reported Outcome Measures in Botulinum Toxin Studies in Aesthetic Medicine. [PDF]
J Cosmet DermatolABSTRACT Background OnabotulinumtoxinA has been licensed for the treatment of upper facial lines for over 20 years. Patient benefits extend well beyond correction of the lines themselves—including positive effects on confidence, self‐esteem, feelings of attractiveness, and age appearance. Regulatory bodies recommend that patient‐reported outcomes (PROs)
Dayan S +7 more
europepmc +2 more sources